Altria’s Analytical Science team conducts chemical and material evaluations and provides scientific strategy and insights to advance Altria’s business goals through regulatory compliance and scientific engagement.

title boxThe team characterizes traditional tobacco products as well as potentially reduced-risk alternatives. By providing robust laboratory-based data and insights, Analytical Science helps Altria expand our portfolio of the Food and Drug Administration (FDA)-authorized, non-combustible products.

Our methods are validated in accordance with the International Conference on Harmonization method validation guideline Q2(R1) Validation of Analytical Procedures: Text and Methodology. We maintain a robust quality system that is accredited to ISO 17025, which provides assurance that the data we generate is precise and accurate.

Standardizing Methods for HPHCs

One of the most important focus areas for our Analytical Science team is working with U.S. and international stakeholders to develop robust standardized methods for the analysis of harmful and potentially harmful constituents (HPHCs) in tobacco products. 

Our scientists serve as national experts and project leaders on the ISO Technical Committee 126 for tobacco and tobacco products and its U.S. mirror committee.  We also actively engage with the Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA) through leadership roles on the Scientific Commission and in various Subgroups and Task Forces. CORESTA study results and Recommended Methods are published at www.coresta.org for use by all stakeholders.

Regina Ballentine

Meet Regina Ballentine

Regina’s scientific work focuses on method development improvements and she recently supported HPHC method development for the on!® Premarket Tobacco Application.  She is experienced on various instrument platforms such as LC, LC-MSMS, GC, GCMS and IC.  Regina has her M.S. in Analytical Chemistry and received a Six Sigma Green Belt from the American Society for Quality.
 
Our Progress
Since 2015:

134

conference presentations

11

publications in peer-reviewed journals

25+

years of ISO 17025
accreditation for our internationally recognized laboratory quality system.

335,000+

yearly analyses
supporting product stewardship, regulatory testing and evaluation of potentially reduced-harm products.

1Altria has an 80% interest in Helix Innovations, LLC, provider of on! nicotine pouches.
2Altria has an exclusive agreement with PMI to sell IQOS products in the United States.
3Altria has a 35% economic interest in JUUL, the U.S. leader in e-vapor.